Bovine spongiform encephalopathy (BSE) surveillance programs
have been employed in numerous countries to monitor BSE prevalence and to
protect animal and human health. Since 1999, the European Commission (EC)
authorized the evaluation and approval of 20 molecular based tests for the rapid
detection of the pathological prion protein (PrPsc) in BSE infection.
The diagnostic sensitivity, convenience, and speed of these tests have made
molecular diagnostics the preferred method for BSE surveillance. The aim of this
study was to determine the analytical sensitivity of 4 commercially available
BSE rapid-test kits, including the Prionics®-Check WESTERN,
the Prionics® Check-PrioSTRIP™, the
BioRad® TeSeE™ ELISA, and the IDEXX®
HerdChek™ EIA. Performances of these tests were then compared
to 2 confirmatory tests, including the BioRad® TeSeE™
Western Blot and the modified Scrapie Associated
Fibrils (SAF)/OIE Immunoblot. One
50% w/v homogenate was made from experimentally generated C-type BSE
brain tissues in ddH2O. Homogenates were diluted through a background
of BSE-negative brainstem homogenate. Masses of both positive and negative
tissues in each dilution were calculated to maintain the appropriate tissue
amounts for each test platform. Specific concentrated homogenization buffer was
added accordingly to maintain the correct buffer condition for each test.
ELISA-based tests were evaluated using their respective software/detection
platforms. Blot-protocols were evaluated by manual measurements of blot signal
density. Detection limitations were determined by fitted curves intersecting the
manufacturers' positive/negative criteria. The confirmatory SAF Immunoblot
displayed the highest analytical sensitivity, followed by the IDEXX®
HerdChek™ EIA, Bio-Rad®
TeSeE™ Western Blot, the Bio-Rad®
TeSeE™ ELISA, Prionics®-Check
PrioSTRIP™, and Prionics®-Check
WESTERN™, respectively. Although the tests performed at different
levels of sensitivity, the most sensitive and least sensitive of the rapid tests
were separated by 2 logs in analytical sensitivity, meeting European performance
requirements. All rapid tests appear suitable for targeted BSE surveillance
programs, as implemented in Canada.